ISPMD consensus on the management of premenstrual disorders

The second consensus meeting of the International Society for Premenstrual Disorders (ISPMD) took place in London during March 2011. The primary goal was to evaluate the published evidence and consider the expert opinions of the ISPMD members to reach a consensus on advice for the management of prem...

Full description

Saved in:
Bibliographic Details
Published in:Archives of women's mental health Vol. 16; no. 4; pp. 279 - 291
Main Authors: Nevatte, Tracy, O’Brien, Patrick Michael Shaughn, Bäckström, Torbjorn, Brown, Candace, Dennerstein, Lorraine, Endicott, Jean, Epperson, C. Neill, Eriksson, Elias, Freeman, Ellen W., Halbreich, Uriel, Ismail, Khalid, Panay, Nicholas, Pearlstein, Teri, Rapkin, Andrea, Reid, Robert, Rubinow, David, Schmidt, Peter, Steiner, Meir, Studd, John, Sundström-Poromaa, Inger, Yonkers, Kimberly
Format: Journal Article
Language:English
Published: Vienna Springer Vienna 01.08.2013
Springer
Springer Nature B.V
Subjects:
Care and treatment
Consensus
Core premenstrual disorder
Development and progression
Diagnosis
Farmakologi och toxikologi
Female
Group Processes
Humans
Medical treatment
Medicine
Medicine & Public Health
Original Article
Pharmacology and Toxicology
PMDD
PMS
Premenstrual disorders
Premenstrual dysphoric disorder
Premenstrual exacerbation
Premenstrual syndrome
Premenstrual Syndrome - classification
Premenstrual Syndrome - epidemiology
Premenstrual Syndrome - therapy
Psychiatry
Psychotherapy
United States - epidemiology
Variant premenstrual disorder
United States
United Kingdom
United Kingdom > UK
Variant premenstrual disorder
Premenstrual exacerbation
Core premenstrual disorder
Premenstrual dysphoric disorder
PMS
PMDD
Premenstrual syndrome
ISSN:1434-1816, 1435-1102, 1435-1102
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The second consensus meeting of the International Society for Premenstrual Disorders (ISPMD) took place in London during March 2011. The primary goal was to evaluate the published evidence and consider the expert opinions of the ISPMD members to reach a consensus on advice for the management of premenstrual disorders. Gynaecologists, psychiatrists, psychologists and pharmacologists each formally presented the evidence within their area of expertise; this was followed by an in-depth discussion leading to consensus recommendations. This article provides a comprehensive review of the outcomes from the meeting. The group discussed and agreed that careful diagnosis based on the recommendations and classification derived from the first ISPMD consensus conference is essential and should underlie the appropriate management strategy. Options for the management of premenstrual disorders fall under two broad categories, (a) those influencing central nervous activity, particularly the modulation of the neurotransmitter serotonin and (b) those that suppress ovulation. Psychotropic medication, such as selective serotonin reuptake inhibitors, probably acts by dampening the influence of sex steroids on the brain. Oral contraceptives, gonadotropin-releasing hormone agonists, danazol and estradiol all most likely function by ovulation suppression. The role of oophorectomy was also considered in this respect. Alternative therapies are also addressed, with, e.g. cognitive behavioural therapy, calcium supplements and Vitex agnus castus warranting further exploration.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1434-1816
1435-1102
1435-1102
DOI:10.1007/s00737-013-0346-y